Literature DB >> 20473778

Differentiation linked regulation of telomerase activity by Makorin-1.

Jose Salvatico1, Joo Hee Kim, In Kwon Chung, Mark T Muller.   

Abstract

To understand telomere homeostasis, a significant aspect of cancer and growth control, it is important to examine telomerase induction as well as mechanisms of regulated elimination. Makorin-1 (MKRN1) was previously shown to be an E3 ubiquitin ligase that targets the telomerase catalytic subunit (hTERT) for proteasome processing (Kim et al., Genes Dev 19:776-781, 2005). In this study we examined expression and regulation of endogenous MKRN1 during the cell cycle and terminal differentiation. When WI-38 cells transition from active growth into a resting G1 state, basal levels of MKRN1 were found to increase by sixfold. In contrast, cancer cells typically contained low or in some cases undetectable levels of MKRN1 protein. HL-60 cells growing exponentially in culture contain no detectable MKRN1; however, following terminal differentiation, MKRN1 mRNA and protein levels are strongly up-regulated while hTERT mRNA, hTERC, and telomerase are shut down. The initial decrease in telomerase activity is due to a gradual reduction in transcription of the hTERT gene that occurs during the first 12 h of terminal differentiation. MKRN1 protein appears between 12 and 24 h and is attended by a more rapid loss of telomerase activity. As more MKRN1 protein accumulates, significantly less telomerase activity is seen. Addition of the proteasome inhibitor, MG132, reverses the loss of telomerase activity; therefore, reductions in telomerase activity are dynamic, ongoing, and correlated with robust up-regulation of MKRN1 as the cells terminally differentiate. The data are consistent with the idea that MKRN1 represents a telomerase elimination pathway to rapidly draw down the activity during differentiation or cell cycle arrest when telomerase action at chromosome ends is no longer necessary.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20473778     DOI: 10.1007/s11010-010-0490-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  53 in total

1.  DNA-protein kinase catalytic subunit-interacting protein KIP binds telomerase by interacting with human telomerase reverse transcriptase.

Authors:  Gun Eui Lee; Eun Young Yu; Chae Hyun Cho; Junho Lee; Mark T Muller; In Kwon Chung
Journal:  J Biol Chem       Date:  2004-06-09       Impact factor: 5.157

Review 2.  Studies of the molecular mechanisms in the regulation of telomerase activity.

Authors:  J P Liu
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

3.  Ubiquitin ligase MKRN1 modulates telomere length homeostasis through a proteolysis of hTERT.

Authors:  Jun Hyun Kim; Sun-Mi Park; Mi Ran Kang; Sue-Young Oh; Tae H Lee; Mark T Muller; In Kwon Chung
Journal:  Genes Dev       Date:  2005-04-01       Impact factor: 11.361

4.  Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma.

Authors:  Jee-Hye Choi; Soo Hyun Park; Jina Park; Borae G Park; Seong-Jae Cha; Kwang-Hoon Kong; Kwang-Ho Lee; Ae Ja Park
Journal:  Biochem Biophys Res Commun       Date:  2007-07-20       Impact factor: 3.575

5.  Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres.

Authors:  Isabelle Guilleret; Jean Benhattar
Journal:  Exp Cell Res       Date:  2003-10-01       Impact factor: 3.905

6.  Telomerase inhibition by retinoids precedes cytodifferentiation of leukemia cells and may contribute to terminal differentiation.

Authors:  Liang Liu; Joel B Berletch; Jessica G Green; Mitchell S Pate; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Mol Cancer Ther       Date:  2004-08       Impact factor: 6.261

7.  Down-regulation of telomerase activity is an early event of cellular differentiation without apparent telomeric DNA change.

Authors:  O Yamada; M Takanashi; M Ujihara; H Mizoguchi
Journal:  Leuk Res       Date:  1998-08       Impact factor: 3.156

8.  Differential regulation of p53 and p21 by MKRN1 E3 ligase controls cell cycle arrest and apoptosis.

Authors:  Eun-Woo Lee; Min-Sik Lee; Suzanne Camus; Jaewang Ghim; Mi-Ran Yang; Wonkyung Oh; Nam-Chul Ha; David P Lane; Jaewhan Song
Journal:  EMBO J       Date:  2009-06-18       Impact factor: 11.598

9.  Telomerase activity in normal and malignant hematopoietic cells.

Authors:  D Broccoli; J W Young; T de Lange
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

10.  CTCF binds the proximal exonic region of hTERT and inhibits its transcription.

Authors:  Stéphanie Renaud; Dmitri Loukinov; Fred T Bosman; Victor Lobanenkov; Jean Benhattar
Journal:  Nucleic Acids Res       Date:  2005-12-02       Impact factor: 16.971

View more
  13 in total

Review 1.  Regulation of the human catalytic subunit of telomerase (hTERT).

Authors:  Michael Daniel; Gregory W Peek; Trygve O Tollefsbol
Journal:  Gene       Date:  2012-02-13       Impact factor: 3.688

2.  Endothelial senescence-associated secretory phenotype (SASP) is regulated by Makorin-1 ubiquitin E3 ligase.

Authors:  Sivareddy Kotla; Nhat-Tu Le; Hang Thi Vu; Kyung Ae Ko; Young Jin Gi; Tamlyn N Thomas; Carolyn Giancursio; Aldos J Lusis; John P Cooke; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Metabolism       Date:  2019-08-30       Impact factor: 8.694

3.  The Long Non-Coding RNA lep-5 Promotes the Juvenile-to-Adult Transition by Destabilizing LIN-28.

Authors:  Karin C Kiontke; R Antonio Herrera; Edward Vuong; Jintao Luo; Erich M Schwarz; David H A Fitch; Douglas S Portman
Journal:  Dev Cell       Date:  2019-04-04       Impact factor: 12.270

4.  The vertebrate makorin ubiquitin ligase gene family has been shaped by large-scale duplication and retroposition from an ancestral gonad-specific, maternal-effect gene.

Authors:  Astrid Böhne; Amandine Darras; Helena D'Cotta; Jean-Francois Baroiller; Delphine Galiana-Arnoux; Jean-Nicolas Volff
Journal:  BMC Genomics       Date:  2010-12-20       Impact factor: 3.969

5.  RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinoma.

Authors:  Robert C Smallridge; Ana-Maria Chindris; Yan W Asmann; John D Casler; Daniel J Serie; Honey V Reddi; Kendall W Cradic; Michael Rivera; Stefan K Grebe; Brian M Necela; Norman L Eberhardt; Jennifer M Carr; Bryan McIver; John A Copland; E Aubrey Thompson
Journal:  J Clin Endocrinol Metab       Date:  2013-12-02       Impact factor: 5.958

6.  MKRN expression pattern during embryonic and post-embryonic organogenesis in rice (Oryza sativa L. var. Nipponbare).

Authors:  Hanumant Baburao Wadekar; Vaidurya Pratap Sahi; Eugene Hayato Morita; Shunnosuke Abe
Journal:  Planta       Date:  2012-12-23       Impact factor: 4.116

7.  Makorin ortholog LEP-2 regulates LIN-28 stability to promote the juvenile-to-adult transition in Caenorhabditis elegans.

Authors:  R Antonio Herrera; Karin Kiontke; David H A Fitch
Journal:  Development       Date:  2016-01-25       Impact factor: 6.868

8.  Identification of human housekeeping genes and tissue-selective genes by microarray meta-analysis.

Authors:  Cheng-Wei Chang; Wei-Chung Cheng; Chaang-Ray Chen; Wun-Yi Shu; Min-Lung Tsai; Ching-Lung Huang; Ian C Hsu
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

9.  Ubiquitous expression of MAKORIN-2 in normal and malignant hematopoietic cells and its growth promoting activity.

Authors:  King Yiu Lee; Kathy Yuen Yee Chan; Kam Sze Tsang; Yang Chao Chen; Hsiang-fu Kung; Pak Cheung Ng; Chi Kong Li; Kam Tong Leung; Karen Li
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

10.  Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.

Authors:  Paul A Cassar; Richard L Carpenedo; Payman Samavarchi-Tehrani; Jonathan B Olsen; Chang Jun Park; Wing Y Chang; Zhaoyi Chen; Chandarong Choey; Sean Delaney; Huishan Guo; Hongbo Guo; R Matthew Tanner; Theodore J Perkins; Scott A Tenenbaum; Andrew Emili; Jeffrey L Wrana; Derrick Gibbings; William L Stanford
Journal:  EMBO Rep       Date:  2015-08-11       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.